Black Opal Ventures, a visionary technology venture capital firm co-founded by Managing Directors Dr. Tara Bishop and Eileen Tanghal, has released its annual Impact Report (link) for 2024. The report showcases the firm’s investment philosophy and celebrates the transformative impact of its portfolio companies, which are leveraging frontier technologies to tackle the world's most pressing and complex challenges in healthcare today.
“U.S. healthcare spending is expected to exceed $6 trillion by 2028,” said Dr. Tara Bishop, Black Opal Ventures co-founder and Managing Director. “Despite this, there are a multitude of unsolved problems, and a dire need for capital to make vital advancements. Our commitment stands behind technologies and companies that address issues while challenging old systems and scaling access. Our investments thrive at the intersection of healthcare and technology, driving innovation to reshape the future of healthcare. By empowering pioneering start-ups, we are fostering advancements that make a meaningful difference in communities across the U.S and globally.”
From fertility labs and surgical centers to oncology pipelines and remote monitoring, Black Opal Ventures' portfolio companies are ushering in a new era of healthcare and life sciences by revolutionizing diagnostics, treatment, and patient care through frontier technologies that are scalable, precise, personalized, and inclusive. They include Ansa Biotechnologies, Blaze.Tech, Conceivable Life Sciences, Empatica, FlyteHealth, Hyro, Oath, Optellum, Outpace, Parasail, and TigerGraph, all of which are utilizing and advancing frontier technology including:
“Frontier technologies are emerging at the intersection of radical scientific breakthroughs and real-world implementation. Our investments are at the collision of healthcare and technology in order to redefine healthcare,” said Eileen Tanghal, co-founder and Managing Director of Black Opal Ventures. “Generative AI, robotics, bioengineering, and advanced computing are transforming how diseases are diagnosed, treated, and prevented—delivering real impact for patients and providers alike.”
Black Opal Ventures strategically aligns its investment approach with several United Nations Sustainable Development Goals (SDGs), particularly SDGs 3 (Good Health and Well-being), 5 (Gender Equality), 9 (Industry, Innovation, and Infrastructure), 10 (Reduced Inequalities), and 16 (Peace, Justice, and Strong Institutions). Black Opal Ventures is driving inclusivity across the venture capital and start-up ecosystems to ensure that technology-driven healthcare solutions reach the communities that need them most.
About Black Opal Ventures:
Black Opal Ventures is a visionary venture capital firm investing in frontier technologies to address the world’s most complex challenges. The firm was founded in 2021 by General Partners Dr. Tara Bishop and Eileen Tanghal. The inaugural fund aims to improve health outcomes by investing in companies at the intersection of science and technology. Learn more at https://www.blackopalventures.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250515419632/en/